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AbstrACt
Objective To determine the feasibility of specialist 
screening practitioners (SSPs) offering patient navigation 
(PN) to facilitate uptake of bowel scope screening (BSS) 
among patients who do not confirm or attend their 
appointment.
Design A single-stage phase II trial.
setting South Tyneside District Hospital, Tyne and Wear, 
England, UK.
Participants Individuals invited for BSS at South Tyneside 
District Hospital during the 6-month recruitment period 
were invited to participate in the study.
Intervention Consenting individuals were randomly 
assigned to either the PN intervention or usual care group 
in a 4:1 ratio. The intervention involved BSS non-attenders 
receiving a phone call from an SSP to elicit their reasons 
for non-attendance and offer educational, practical and 
emotional support as required. If requested by the patient, 
another BSS appointment was then scheduled.
Primary outcome measure The number of non-attenders 
in the intervention group who were navigated and then 
rebooked and attended their new BSS appointment.
secondary outcome measures Barriers to BSS 
attendance, patient-reported outcomes including informed 
choice and satisfaction with BSS and the PN intervention, 
reasons for study non-participation, SSPs’ evaluation of 
the PN process and a cost analysis.
results Of those invited to take part (n=1050), 
152 (14.5%) were randomised into the study: PN 
intervention=109; usual care=43. Most participants 
attended their BSS appointment (PN: 79.8%; control: 
79.1%) leaving 22 eligible for PN: only two were 
successfully contacted. SSPs were confident in delivering 
PN, but were concerned that low BSS awareness and 
information overload may have deterred patients from 
taking part in the study. Difficulty contacting patients was 
reported as a burden to their workload.
Conclusions PN, as implemented, was not a feasible 
intervention to increase BSS uptake in South Tyneside. 
Interventions to increase BSS awareness may be better 
suited to this population.
trial registration number ISRCTN13314752; Results.
IntrODuCtIOn 
Colorectal cancer (CRC) is the second most 
common cause of cancer death in the UK.1 
In 2013, the National Health Service (NHS) 
Bowel Cancer Screening Programme (BCSP) 
introduced bowel scope screening (BSS) for 
men and women aged 55 years. BSS involves 
a once-only flexible sigmoidoscopy, a test that 
can substantially reduce CRC incidence and 
mortality by finding and removing precan-
cerous polyps. However, the benefits of BSS 
are dependent on uptake, which is currently 
less than optimal at 43.1%, a figure that 
falls further when the focus is on the more 
deprived areas of England.2 There is, there-
fore, a need for interventions to increase 
BSS uptake and reduce the observed social 
gradient.
Patient navigation (PN) is an intervention 
that aims to remove logistical or psycholog-
ical barriers to healthcare. It involves the 
provision of one-to-one tailored support from 
trained individuals (ie, patient navigators) to 
patients who need it. This may be delivered 
strengths and limitations of this study
 ► This study was the first to consider patient naviga-
tion as an intervention to increase uptake of bowel 
scope screening (BSS)  as part of the UK National 
Health Service Bowel Cancer Screening Programme.
 ► We aimed to use the already advanced knowledge 
and communication skills of specialist screening 
practitioners for the delivery of the intervention.
 ► Contact information obtained by the Bowel Cancer 
Screening Programme for people to be invited for 
BSS does not include telephone numbers and, there-
fore, an opt-in consent process was a necessary de-
sign feature for this study.
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face to face or via telephone. The concept of PN was orig-
inally developed in the USA, in 1990, by Harold Freeman, 
mainly in the context of breast cancer screening for 
patients of low socioeconomic status.3 However, it has 
since been applied to other cancer types and chronic 
diseases across the healthcare continuum, from preven-
tion to end of life.4
There is a lot of US evidence that PN can increase CRC 
screening uptake. A randomised controlled trial showed 
significantly higher rates of screening (completion of 
either a faecal occult blood test (FOBT) or colonos-
copy) among patients in a PN intervention group (35%), 
compared with those in a control group (20%).5 More 
recently, DeGroff et al6 found that low-income patients 
who received a PN intervention were one and a half times 
more likely to attend colonoscopy than control partici-
pants receiving usual care.6 Similarly, Rice et al7 found 
patients assigned to a PN intervention condition were 
11.2 times more likely to attend colonoscopy than those 
in the control condition.7 Patients in the navigation inter-
vention group were also significantly more likely to have 
adequate bowel preparation and significantly less likely 
to miss or cancel their appointments.7 Although PN has 
not yet been applied to BSS in the UK, it has successfully 
been used to increase uptake of breast screening among 
African-Caribbean women in two socially diverse areas of 
London.8 Moreover, a further single-site study in London 
explored whether a telephone call from a general practi-
tioner or healthcare assistant to patients who had failed 
to respond to their NHS BCSP invitation to complete an 
FOBT could help increase screening uptake.9 The call 
aimed to identify reasons for their non-response and 
encourage participation. The results indicated that the 
call was successful, with 66% of those contacted agreeing 
to be screened and 50% then completing the test.9 This 
suggests that a PN telephone intervention could be an 
effective method to promote BSS attendance in the UK.
The main aim of this study was to determine the feasi-
bility of employing specialist screening practitioners 
(SSPs), who are based within screening centres and 
whose day-to-day role is to support patients through the 
screening process, to additionally offer PN to patients who 
do not confirm or attend their BSS appointment. The 
advantage of delivering PN through screening centres as 
opposed to primary care was the already available infra-
structure to support patients through their screening 
journey, for example, readily available expertise and 
knowledge regarding BSS and the BCSP, skills communi-
cating with the public about cancer and screening tests, 
and the ability to directly coordinate amendments to 
screening invitations, for example, rescheduling appoint-
ments, arranging for the enema to be administered at 
the hospital. The main potential barrier to delivering PN 
in this way was that screening centres do not have access 
to the telephone numbers of screening invitees. The 
objectives of this study were, therefore, to determine the 
feasibility of screening centre delivered PN by assessing 
study recruitment rates (specifically the proportion of 
screening invitees willing to consent to taking part and 
sharing their contact details); BSS uptake rates of those 
navigated; patients’ satisfaction with PN; SSPs’ satisfaction 
with PN and the cost of delivering the PN intervention.
MethOD
Design
We used a single-stage phase II trial to determine whether 
PN could positively impact the BSS attendance rate in 
South Tyneside to a degree that would merit further 
investigation. The protocol for this research has previ-
ously been published and should be consulted for addi-
tional methodological detail.10 
recruitment and setting
All individuals invited for BSS at South Tyneside District 
Hospital (STDH; one of three sites operating under the 
South of Tyne Screening Centre) during the recruitment 
period (May to October 2015) were invited to take part 
in this study. The South of Tyne Screening Centre was 
chosen because it has below average uptake of BSS, with 
37% of invited adults attending screening.2
Procedure
A study invitation was sent with the standard BSS prein-
vitation letter and included a participant information 
sheet (PIS) and consent form to be completed and 
returned by those who wished to participate in the study. 
The PIS detailed information about the aim of the study, 
consent process, data protection and study procedure, 
including the telephone number that would appear on 
their screen if they were to receive a PN phone call. It also 
stated that deciding to take part in the study was not the 
same as deciding to take part in screening. The consent 
form asked individuals to indicate their gender, contact 
number, name and address. Individuals who did not 
want to participate were asked to complete and return an 
anonymised non-participation postcard (A5 size), using 
the presented tick box options and free-text space to indi-
cate their reason(s) for non-participation (online supple-
mentary file A).
The research nurse allocated (unblinded) consenting 
individuals to either the PN intervention or control group 
using a pregenerated, gender-specific randomisation list 
(provided by medical statistician). An initial randomisa-
tion ratio of 2:1 in favour of the intervention was soon 
increased to 4:1 due to a low response rate.
As per usual care, 2 weeks after receiving the prein-
vitation letter, consenting participants received a BSS 
appointment date and time (6 weeks in advance). This 
letter requested confirmation of their intention to attend 
the appointment (return of slip or call to centre). If 
no confirmation was received within 2 weeks, the bowel 
cancer screening hub sent a reminder letter. If confirma-
tion was not received within a further 2 weeks, a cancella-
tion letter was then sent. For those in the control group, 
there was no further contact from the screening centre. If 
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the appointment was confirmed, an enema with instruc-
tions was mailed out approximately 2 weeks before the 
appointment. Patients who confirmed but then failed to 
attend received a ‘DNA’ letter. For those in the control 
group, again no further contact was made.
For those in the PN group, the PN intervention began 
following the mail out of the cancellation or ‘DNA’ letter. 
In addition to the original protocol, the PN intervention 
was also initiated following a call made by a patient to 
the screening centre to cancel their BSS appointment 
without an intention to rebook at a later date. For those 
who phoned to cancel an appointment with a plan to call 
back and rebook, the PN intervention was only initiated 
if no new appointment was made within 6–8 weeks. As 
per study protocol, the PN intervention involved an SSP 
trained in how to deliver PN, telephoning the individual 
to elicit reasons for non-attendance, to provide emotional 
and instrumental support to overcome any barriers iden-
tified (eg, assistance with the enema), and, if relevant, 
to help arrange a new appointment.10 Good practice 
required the participant to confirm their agreement to 
the call being recorded at the start of the PN call.
All participants were sent one of four versions of an End 
of Study Questionnaire (ESQ) approximately 4 weeks 
after attendance at their BSS appointment, or 1 week 
after non-attendance or an unsuccessful PN call (ie, no 
response or no new appointment agreed). Questions 
varied across versions depending on relevance to study 
group and attendance status but generally included ques-
tions pertaining to demographic details, BSS knowledge 
and decision experience and satisfaction. For those who 
attended, additional questions included the test experi-
ence and views on the support they received. Specifically, 
patient-reported pain and embarrassment were explored 
as these are common barriers to screening uptake.11–16 
The ESQ for patients who received PN also aimed to 
explore the cognitive and emotional response to the 
intervention and its effect on informed choice and BSS 
knowledge. If ESQs were not returned within 2 weeks, a 
second ESQ was sent as a reminder.
ssP interviews
The six SSPs (all female) trained to deliver PN were inter-
viewed at the end of the study to elicit their perspectives 
on the delivery of the intervention, including barriers 
and facilitators, and how PN would likely affect their 
workload if implemented. Semistructured telephone 
interviews were carried out by the patient representative 
(LB) involved in the study and recorded. Following tran-
scription, the interviews were then analysed for recurrent 
themes using a thematic analysis.
Patient involvement
The research question was developed as part of a stake-
holder meeting which included three patient representa-
tives. The meeting introduced the PN concept, reviewed 
previous evidence supporting its use and determined 
the suitability of this strategy in the English context. The 
meeting also determined the appropriateness of using 
a feasibility study, the specific way in which PN should 
be delivered (eg, by SSPs) and the potential for patient 
and public involvement (PPI) going forward. One of our 
attending patient representatives became a coinvestigator 
and was involved in reviewing drafts of the protocol, 
recruitment materials, the lay summary, conference 
abstracts and reports. In addition, our patient represen-
tative (LB) went on to help develop the SSP interview 
schedule, then conducted the interviews, coanalysed the 
transcripts and disseminated the results at a conference.
Cost analysis
We undertook a detailed bottom-up microcosting exer-
cise to calculate the average cost per participant of 
PN and usual care. Costs mainly comprised staff time 
and stationary (stamps, envelopes, paper, postage and 
printing charges) associated with the following activities: 
(1) the preinvitation letter introducing BSS; (2) the invi-
tation letter to participate in BSS with an appointment 
date; (3) the reminder letter sent if no confirmation is 
received from the patient; (4) the cancellation letter sent 
to participants if there is no reply to the reminder letter 
and (5) instructions on how to participate in BSS sent to 
participants if confirmation is received. In addition, for 
PN, we also included the cost of PN training and the cost 
of PN contacts in the event that patients did not respond 
to the invitation or did not attend a confirmed appoint-
ment. Unit costs were taken from market prices.
results
response rate
The response rate was 14.6% (153 out of 1050), which was 
significantly below the target of 40%.10 One consent form 
was received after the individual had attended their sched-
uled BSS appointment and was therefore excluded from 
randomisation, resulting in 43 participants randomly allo-
cated to the control group (female=23; 53.5%) and 109 
to the intervention (PN) group (female=58; 53.2%). The 
non-randomised individual (female) was included in the 
evaluation and sent an ESQ.
study decliners
Non-participation postcards were returned by 16 people 
(1.8% of 897 non-consenting invitees). The most 
commonly reported reasons for non-participation were ‘I 
have already decided not to have the BSS test’ (43.8%; 
n=7), and ‘I do not want to receive additional phone calls 
from the screening centre’ (37.5%; n=6). Other reasons 
for not having the test mostly focused on people currently 
feeling well/content with life and not wanting to alter this 
by getting involved in screening.
bss participation by study group
The majority of participants attended their original BSS 
appointment: control=79.1% and PN=79.8%. This level of 
attendance was much higher than the 35% average for 
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STDH over the study period. (Ritchie, personal commu-
nication, 2016) As a result, only 22 people were eligible 
for the intervention: 12 failed to confirm their appoint-
ment, 4 failed to attend a confirmed appointment and 6 
cancelled their appointment. However, SSPs only called 
19 participants as three were lost to follow-up (ie, errone-
ously not highlighted as needing PN intervention) and 
only two received PN. The PN received was of a relatively 
‘low level’: one PN call was audio recorded (2 min 54 s), 
and it revealed that the only reason for non-attendance 
was that the individual’s GP had recently referred them 
for bowel investigations. For the second PN call, the 
individual stated that they had forgotten their appoint-
ment and asked to rebook before permission to record 
was obtained. Of the remaining participants, 10 failed to 
answer all call attempts, 4 had an invalid or wrong number 
and 3 answered but declined participation (see figure 1).
Attendance follow-up (intention to treat)
Attendance data were assessed for each consenting indi-
vidual, 3 months after the last PN call attempt was made. 
In this time, one control participant had self-referred and 
attended a new BSS appointment and three PN partici-
pants (one failed to answer PN calls, one received a PN 
call and one was lost within the study and so the PN inter-
vention was not attempted) rebooked and attended a BSS 
appointment. BSS attendance levels then increased to 
81.4% (n=35) and 82.6% (n=90) for the control and PN 
groups, respectively.
end of study Questionnaires
One hundred and ten participants completed ESQs; the 
majority of these had attended their original BSS appoint-
ment (n=104; male=54) and therefore none had received 
the PN intervention. While comparisons between those 
who did and did not receive the intervention were not 
possible, useful data emerged regarding the BSS expe-
rience: 98.1% were satisfied with their choice to attend, 
97.2% were satisfied with their test experience and 100% 
were satisfied with the support they received throughout 
the BSS experience. The majority of participants reported 
no or mild pain (59.6%) and indicated no or mild embar-
rassment (78.9%). Furthermore, 30.4% found it less 
painful and 46.2% less embarrassing than expected. 
Table 1 shows the breakdown of these responses.
Although the majority of attendees were able to 
correctly answer 10 knowledge questions presented 
regarding BSS, there remained a notable percentage of 
BSS attendees who answered these questions incorrectly 
or with uncertainty. For example, 23% did not believe 
that BSS can help prevent bowel cancer and 18% did 
not consider bowel cancer to be a common cancer. Of 
Figure 1 Flow diagram of study participation. ESQ, End of Study Questionnaire; PN, patient navigation.
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particular interest was that 60% did not know that BSS 
was a one-off test.
ssP interviews
All six SSPs were interviewed (range:19–41 min). Overall, 
SSPs found the PN training to be very useful and were 
confident in delivering the intervention. However, they 
also expressed some concerns about PN and highlighted 
possible reasons why it was unsuccessful for this patient 
group. SSPs felt that within South Tyneside, individuals 
not wanting to attend BSS would also not want to discuss 
their reasons:
If they’re not going to take part in something then 
you’re probably not going to consent to be contacted 
after because you’ve already made your mind up that 
you’re not going to attend. (SSP5)
Additionally, they mentioned that people in their 
area were largely unaware of BSS, and some would have 
been anxious on receiving the invitation letters as a 
consequence:
I think because people don’t really know what bow-
el scope screening is. I think some people were 
frightened because they thought that their GPs had 
referred them in. I think there’s not enough informa-
tion out about bowel scope screening as yet. (SSP4)
SSPs also worried that patients would have been over-
whelmed by all the information they received about both 
BSS and the study simultaneously, and this may have 
deterred some individuals from participating. This may 
also have caused confusion about whether patients were 
consenting to take part in screening or a research study, 
and perhaps some attended screening under the assump-
tion that it was part of the study:
I think it was confusing for them. I think they received 
a lot of information because they were receiving the 
navigation information and they were also receiving 
information regarding bowel screening. I think it was 
probably too much all at one time for them to com-
prehend. I think it probably put some patients off, 
and certainly from the experience that I had from 
consenting people for bowel scope screening. One 
lady that springs to mind was a school teacher; she 
thought that she was consenting for a study rather 
than for a screening investigation. I think it created 
confusion. (SSP4)
In addition, SSPs expressed difficulty with trying to 
contact non-responders eligible for PN, and commented 
that many participants had provided false telephone 
numbers or did not answer. Those they were able to 
contact often hung up or seemed uninterested in talking 
to them. These difficulties in contacting patients meant 
SSPs needed to repeat phone calls on different days and 
times, which was perceived as a demanding addition to 
their workload:
‘I’ve been ringing the patients on different days, dif-
ferent times of the day, that sort of thing, to try and… 
if people are at work and things, to try and catch 
them when they’re there. So, doing it on top [of] my 
everyday other clinical commitments, it has actually 
been quite a demand.’ (SSP3)
Cost analysis
The mean costs per participant of PN and usual care were 
£18.92 and £12.10, respectively. The difference in costs 
Table 1 End of Study Questionnaires
Question
Attenders (n=104)
% (n)
I am satisfied with my choice to attend bowel scope 
screening (BSS)
  Strongly agree 67.3 (70)
  Agree 30.8 (32)
  Disagree 1.0 (1)
  Strongly disagree 1.0 (1)
Overall, how satisfied were you with your test experience?
  Very satisfied 63.5 (66)
  Satisfied 33.7 (35)
  Dissatisfied 1.0 (1)
  Very dissatisfied 1.9 (2)
Overall, how satisfied were you with the level of support you 
received throughout the BSS experience?
  Very satisfied 88.5 (92)
  Satisfied 11.5 (12)
  Dissatisfied 0.0 (0)
  Very dissatisfied 0.0 (0)
How much pain did you feel during your test?
  None 17.3 (18)
  Mild 42.3 (44)
  Moderate 27.9 (29)
  Severe 12.5 (13)
Was your test more or less painful than you expected?
  More painful 23.5 (24)
  As expected 45.1 (46)
  Less painful 30.4 (31)
How much embarrassment did you feel during your test
  None 43.3 (45)
  Mild 35.6 (37)
  Moderate 17.3 (18)
  Severe 3.8 (4)
Was your test more or less embarrassing than you 
expected?
  More embarrassing 5.8 (6)
  As expected 48.1 (50)
  Less embarrassing 46.2 (48)
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(£6.72 per participant) was driven mainly by the cost of 
SSP time associated with trying to contact non-responders.
DIsCussIOn
This study explored the feasibility of SSPs offering PN 
to patients at South Tyneside Screening Centre who 
did not confirm or attend their appointment, in order 
to engage/re-engage them with the opportunity to have 
BSS. The introduction of PN, with this patient group, was 
not found to be feasible within the current programme 
structure.
This was the first study to apply PN to BSS in an area 
of low uptake in the UK. A range of quantitative and 
qualitative data was gathered to assess the feasibility of 
the intervention, including BSS attendance, reasons for 
study non-participation, informed choice about BSS, an 
SSP evaluation and a cost evaluation. The study provides 
important practical implications, because it suggests 
that SSP-led PN is currently not a feasible method for 
increasing screening uptake, in areas where BSS is low, 
predominantly due to restricted access to contact details. 
A cost analysis also suggested that compared with other 
interventions aimed at increasing BSS uptake, PN was 
slightly more expensive to deliver, though the cost impli-
cations were modest and we cannot give a fair evaluation 
of the money saved through the prevention of CRC had 
the PN process not been restricted.
The main challenge of this study was the recruitment 
of prospective BSS invitees which led to a biased, self-se-
lected sample of highly motivated participants. SSPs 
suggested that the main problem lay with sending study 
invitations alongside the BSS preinvitations. While this 
was the only option in the context of an SSP-led study, it 
appeared to cause confusion among some patients, with 
an example given by one SSP of a woman assuming she 
was taking part in the study when she was attending her 
BSS appointment. Indeed, this aspect of the study design, 
while included to allow ease of access to appropriate 
patients, to avoid an additional mail out and to keep it 
separate from receipt of the BSS appointment letter, may 
still have led to information overload, negatively affecting 
participation rates.
This design element also related to the main obstacle 
for PN in the screening context, namely the lack of avail-
ability of patient telephone numbers by the screening 
programme. As a result, we had to ask participants to 
provide their telephone number during the study consent 
process. This meant there was a selection bias, because we 
were only able to contact individuals who were engaged 
with BSS and willing to take part in research, rather than 
those who were unengaged and arguably most in need 
of navigation (eg, those who did not read the invitation 
letters). SSPs commented that they felt that those who did 
not want to take part in BSS may have also not wanted 
to discuss BSS and their reasons for non-attendance with 
them over the phone. It was, therefore, not surprising 
that the uptake was much higher in our sample (79% and 
80% in the control and intervention groups, respectively) 
compared with uptake observed within South Tyneside 
generally (37%) and specifically within STDH (35%) 
during the study period.2 (Ritchie, personal communica-
tion, 2016).
SSPs also faced great difficulty establishing contact with 
participants who had consented to the study, with many 
unanswered calls and false telephone numbers provided. 
It was not possible to verify telephone numbers ahead of 
the PN intervention and we were not able to assess and 
compare the proportion of incorrect telephone numbers 
in the control group. While one SSP considered this a 
‘mischievous side’ of the population, we perhaps could 
have benefited from asking consenting participants to 
provide an indication of the best day and time to contact 
them by phone. Additionally, as per usual practice within 
the centre, navigators did not leave voicemail messages, 
but this may have helped alert patients to a subsequent 
call and perhaps offered reassurance of the friendly voice 
they were likely to receive following their non-response or 
non-attendance. A request for the patient to confirm their 
agreement to the recording of the call before proceeding 
with PN may also have put people off continuing the 
conversation.
Future research would benefit from finding ways to 
contact patients without first having them provide their 
number and consent to being called. For example, by 
providing the navigation service through primary care 
(using healthcare assistants, nurses or volunteers trained 
in BSS navigation), the telephone numbers of patients 
will already be available and a call from their general 
practice may be considered a more familiar and accept-
able approach. However, in a study involving telephone 
communication through a general practice in a socio-
economically deprived area in London to increase FOBT 
uptake specifically, similar difficulties ensued; 46% of 
patients to be contacted had an incorrect number or no 
number at all documented.9 Exploration of using other 
communication avenues to personally promote health-
care initiatives and opportunities to unengaged audi-
ences is required.
The observation from SSP interviews that BSS aware-
ness is low in South Tyneside suggests that an interven-
tion to raise awareness might initially be more useful than 
PN in increasing BSS uptake in future. It is possible that 
PN is better suited to patients who are already aware of 
an available opportunity or concept. Alternatively, a deci-
sion aid could perhaps be used in future, alongside or 
ahead of PN, to help increase patients’ knowledge of BSS, 
including its risks and benefits, and encourage consid-
eration of the test. A recent American study found that 
providing patients with a decision aid, as well as PN, led 
to greatly increased bowel cancer screening uptake within 
6 months when compared with usual care (68% vs 27%).17
To conclude, PN provided by SSPs was not found to be 
a feasible intervention to increase BSS among patients in 
South Tyneside Screening Centre. This was likely due to 
the lack of access to patient telephone numbers, causing 
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a selection bias whereby mostly patients engaged with 
BSS participated in the research, and thus, those most 
in need of navigation were uncontactable. In addition to 
this, there were difficulties contacting patients who had 
consented to the study, including unanswered calls and 
false telephone numbers. Subsequently, the feasibility of 
PN as an intervention in itself could not be assessed with 
this population. While the delivery of PN was not possible 
in the present study, alternative strategies to allow an 
evaluation of the impact of a personalised navigation 
approach to help patients in England engage with bowel 
screening opportunities are sought.
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